Common neuroprotective effects of endothelin receptor a blockade and erythropoietin during hypoxia-associated cell injury. Perspectives of combined treatment.
Danielyan
Lusine
L
Department of Clinical Pharmacology, University Hospital of Tuebingen, Otfried-Mueller Str. 45, D-72076 Tuebingen, Germany. lusine.danielyan@med.uni-tuebingen.de
Buniatian
Gayane H
GH
Gleiter
Christoph H
CH
D065130:Endothelin A Receptor Antagonists; D004921:Erythropoietin / Q000502:physiology*; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy*; D018919:Neovascularization, Physiologic; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D014947:Wounds and Injuries / Q000188:drug therapy*
D065130:Endothelin A Receptor Antagonists; D018696:Neuroprotective Agents; D004921:Erythropoietin